Title:
ＬＰＡアンタゴニストとしてのトリアゾールカルボン酸
Document Type and Number:
Japanese Patent JP7465898
Kind Code:
B2
Abstract:
The present invention provides compounds of Formula (I), or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
Inventors:
Chen, Peter Tai Wah
Jean, Hao
Kaltenbach, Robert F., The Third
Li, Jun
Shi, Jun
Tao Seaway
Shi, Yang
Jean, Hao
Kaltenbach, Robert F., The Third
Li, Jun
Shi, Jun
Tao Seaway
Shi, Yang
Application Number:
JP2021575473A
Publication Date:
April 11, 2024
Filing Date:
June 16, 2020
Export Citation:
Assignee:
BRISTOL-MYERS SQUIBB COMPANY
International Classes:
C07D401/04; A61K31/4439; A61K31/506; A61P1/16; A61P9/10; A61P11/00; A61P13/12; A61P17/00; A61P19/10; A61P27/02; A61P29/00; A61P35/00; A61P35/02; A61P35/04; A61P37/06; C07D401/14; C07D405/14; C07D407/14; C07D413/14
Domestic Patent References:
| JP2013501064A | ||||
| JP2012528884A |
Foreign References:
| WO2017223016A1 | ||||
| WO2005012269A1 |
Other References:
周東智,有機医薬分子論,2012年,p.201-18
Attorney, Agent or Firm:
Norito Yamao
Nagatoshi Shinagawa
Futami Kamahira
Masahiro Suwon
Wu Yingyan
Nagatoshi Shinagawa
Futami Kamahira
Masahiro Suwon
Wu Yingyan